drugset / Trial / NCT04651088

Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

NCT04651088

Phase 0 Not yet recruiting 15 enrolled University of Texas Southwestern Medical Center
Non-randomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to compare over the counter and alternative prescription urinary alkalinizing agents to slow release potassium citrate in their ability to modify urinary parameters associated with stone formation.

Timeline

Start
2026-07-01
Primary completion
2026-12
Completion
2027-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 20 meq
Comparator Potassium Bicarbonate Small molecule 20 meq
Comparator sodium bicarbonate Diagnostic / imaging agent 1950 mg

Indications